share_log

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $15

HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $15

HC Wainwright & Co.维持对Ocular Therapeutix的买入,将目标股价上调至15美元
Benzinga ·  03/13 06:46

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $12 to $15.

HC Wainwright & Co. 分析师陈毅维持Ocular Therapeutix(纳斯达克股票代码:OCUL)的买入并将目标股价从12美元上调至15美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发